Cwm, LLC Supernus Pharmaceuticals, Inc. Transaction History

Cwm, LLC

$33.3 Billion
Q3 2025

A detailed history of Cwm, LLC transactions in Supernus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cwm, LLC holds 3,656 shares of SUPN stock, worth $164,520. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,656

Previous 3,080 18.7%

Holding current value

$164,520

Previous $97,000 80.41%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$31.45 - $47.79 $18,115 - $27,527	576 Added 18.7%	3,656 $175,000
Q2 2025 Jul 25, 2025	BUY	$30.29 - $33.43 $44,798 - $49,442	1,479 Added 92.38%	3,080 $97,000
Q1 2025 May 01, 2025	SELL	$31.17 - $40.0 $2,244 - $2,880	-72 Reduced 4.3%	1,601 $52,000
Q4 2024 Feb 04, 2025	BUY	$31.89 - $37.83 $14,350 - $17,023	450 Added 36.79%	1,673 $60,000
Q3 2024 Oct 08, 2024	BUY	$25.77 - $35.16 $10,926 - $14,907	424 Added 53.07%	1,223 $38,000

Q2 2024 Jul 09, 2024	SELL	$25.99 - $33.85 $3,066 - $3,994	-118 Reduced 12.87%	799 $21,000
Q1 2024 Apr 05, 2024	BUY	$27.11 - $35.17 $3,226 - $4,185	119 Added 14.91%	917 $31,000
Q4 2023 Feb 01, 2024	BUY	$22.72 - $29.68 $13,881 - $18,134	611 Added 326.74%	798 $23,000
Q3 2023 Oct 11, 2023	BUY	$27.57 - $32.91 $523 - $625	19 Added 11.31%	187 $5,000
Q2 2023 Aug 03, 2023	SELL	$29.91 - $38.73 $5,114 - $6,622	-171 Reduced 50.44%	168 $5,000
Q1 2023 Apr 28, 2023	BUY	$34.93 - $42.03 $2,514 - $3,026	72 Added 26.97%	339 $12,000
Q4 2022 Feb 01, 2023	SELL	$31.09 - $37.88 $466 - $568	-15 Reduced 5.32%	267 $10,000
Q3 2022 Oct 27, 2022	BUY	$28.79 - $35.41 $2,850 - $3,505	99 Added 54.1%	282 $10,000
Q1 2022 Apr 21, 2022	SELL	$28.51 - $32.9 $513 - $592	-18 Reduced 8.96%	183 $6,000
Q4 2021 Jan 31, 2022	BUY	$26.37 - $34.22 $3,744 - $4,859	142 Added 240.68%	201 $6,000
Q4 2019 Sep 14, 2021	BUY	$19.93 - $29.13 $1,175 - $1,718	59 New	59 $2,000
Q4 2019 Jan 27, 2020	SELL	$19.93 - $29.13 $1,175 - $1,718	-59 Closed	0 $0
Q3 2019 Sep 14, 2021	BUY	$25.47 - $33.37 $1,502 - $1,968	59 New	59 $2,000
Q3 2019 Oct 22, 2019	SELL	$25.47 - $33.37 $1,502 - $1,968	-59 Closed	0 $0
Q2 2019 Sep 14, 2021	BUY	$29.96 - $38.87 $1,767 - $2,293	59 New	59 $2,000
Q2 2019 Jul 31, 2019	SELL	$29.96 - $38.87 $1,767 - $2,293	-59 Closed	0 $0
Q1 2019 Sep 02, 2021	BUY	$32.77 - $41.99 $1,572 - $2,015	48 Added 436.36%	59 $0
Q1 2019 Apr 22, 2019	BUY	$32.77 - $41.99 $360 - $461	11 New	11 $0

Others Institutions Holding SUPN

# of Institutions

330

Shares Held

60.2M

Call Options Held

234K

Put Options Held

View Full List

About SUPERNUS PHARMACEUTICALS, INC.

Ticker SUPN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,495,300
Market Cap $2.41B
Description
Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extended release topiramate product indicated for the treatment of epilepsy, as well as for the prop...

More about SUPN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.

Account